Dai-ichi Life HoldingsInc (JP:8750)
:8750
Top Page
Dai-ichi Life Holdings
(8750)
Select Model
Select Model
Rating:67Neutral
Price Target:
¥1,540.00
▲(10.00% Upside)
Action:ReiteratedDate:02/28/26
The score is driven primarily by mixed financial performance: a solid balance sheet and improved profitability are offset by declining revenue and weaker operating cash conversion. Technicals are supportive due to a strong uptrend, though momentum is near overbought. Valuation is reasonable with a moderate P/E and dividend yield.
Positive Factors
Balance Sheet Strength
A moderate leverage profile (debt-to-equity 0.34) and improved ROE (12.38%) point to capital efficiency and financial resilience. This durable strength supports absorbing underwriting volatility, maintaining creditworthiness, and funding strategic needs across insurance and asset management over months.
Negative Factors
Revenue Decline
A persistent revenue decline (-7.62%) reduces scale and limits margin leverage in insurance operations. If premium, fee, or sales trends remain weak, the company faces pressure on earnings growth, reserve funding capacity, and its ability to invest in distribution or product development over coming quarters.
Read all positive and negative factors
Positive Factors
Negative Factors
Balance Sheet Strength
A moderate leverage profile (debt-to-equity 0.34) and improved ROE (12.38%) point to capital efficiency and financial resilience. This durable strength supports absorbing underwriting volatility, maintaining creditworthiness, and funding strategic needs across insurance and asset management over months.
Read all positive factors
Dai-ichi Life Holdings (8750) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥5.50T
Dividend Yield3.26%
Average Volume (3M)8.51M
Price to Earnings (P/E)7.4
Beta (1Y)1.27
Revenue Growth-8.02%
EPS Growth5.21%
CountryJP
Employees59,495
SectorFinancial
Sector Strength70
IndustryInsurance - Life
Share Statistics
EPS (TTM)44.13
Shares Outstanding3,693,132,300
10 Day Avg. Volume9,863,640
30 Day Avg. Volume8,511,503
Financial Highlights & Ratios
PEG Ratio0.24
Price to Book (P/B)1.21
Price to Sales (P/S)0.48
P/FCF Ratio7.88
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥1,690.00Price Target Upside20.71% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8
EPS Forecast (FY)126.58
Revenue Forecast (FY)¥10.35T
Dai-ichi Life Holdings Business Overview & Revenue Model
Company Description
Dai-ichi Life Holdings, Inc., through its subsidiaries, provides life insurance products in Japan, the United States, and internationally. It operates through Domestic Life Insurance Business, Overseas Insurance Business, and Other Business segmen...
How the Company Makes Money
The company makes money primarily through its insurance operations and investment activities. In its life insurance business, it earns premium income from policyholders and generates profit based on underwriting results (premiums collected minus c...
Dai-ichi Life Holdings Financial Statement Overview
Summary
Income Statement
65
Positive
Balance Sheet
70
Positive
Cash Flow
60
Neutral
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 8.48T | 8.80T | 9.56T | 7.71T | 7.10T | 6.80T |
| Gross Profit | 4.69T | 5.01T | 5.96T | 4.31T | 4.22T | 4.19T |
| EBITDA | 502.81B | 743.39B | 565.73B | 395.01B | 591.04B | 589.33B |
| Net Income | 337.54B | 429.61B | 320.76B | 173.74B | 409.35B | 363.78B |
Balance Sheet | ||||||
| Total Assets | 68.59T | 69.59T | 67.54T | 61.58T | 65.88T | 63.59T |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 1.89T | 2.06T | 1.62T | 2.18T | 1.88T |
| Total Debt | 1.14T | 1.19T | 2.41T | 2.04T | 4.74T | 3.54T |
| Total Liabilities | 65.01T | 66.12T | 63.66T | 58.71T | 61.47T | 58.79T |
| Stockholders Equity | 3.58T | 3.47T | 3.88T | 2.66T | 4.41T | 4.81T |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 532.46B | 946.24B | -250.35B | -561.54B | -118.07B |
| Operating Cash Flow | 0.00 | 592.58B | 997.38B | -132.49B | -462.08B | -79.90B |
| Investing Cash Flow | 0.00 | -968.03B | -644.92B | 117.10B | 940.87B | 615.10B |
| Financing Cash Flow | 0.00 | -73.57B | -145.76B | -325.45B | -180.71B | 65.59B |
Dai-ichi Life Holdings Technical Analysis
Positive
1400.00
Price Trends
1434.81
Positive
1343.44
Positive
1228.46
Positive
Market Momentum
14.67
Negative
61.50
Neutral
76.83
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:8750, the sentiment is Positive. The current price of 1400 is below the 20-day moving average (MA) of 1425.01, below the 50-day MA of 1434.81, and above the 200-day MA of 1228.46, indicating a bullish trend. The MACD of 14.67 indicates Negative momentum. The RSI at 61.50 is Neutral, neither overbought nor oversold. The STOCH value of 76.83 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:8750.
Dai-ichi Life Holdings Peers Comparison
UnderperformOutperform
Sector (68)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥5.53T | 7.65 | ― | 2.82% | 11.37% | 27.90% | |
72 Outperform | ¥6.05T | 8.22 | 16.97% | 2.59% | 23.01% | 2.59% | |
72 Outperform | ¥2.05T | 3.01 | 20.02% | 2.63% | 23.96% | 179.16% | |
72 Outperform | ¥1.76T | 17.60 | ― | 2.44% | -21.38% | 58.05% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | ¥5.50T | 7.36 | 10.61% | 3.26% | -8.02% | 5.21% | |
61 Neutral | ¥1.74T | 10.62 | 7.91% | 2.74% | -1.96% | 10.32% |
* Financial Sector Average
JP:8750
Dai-ichi Life Holdings
1,496.50
578.20
62.96%
JP:8725
MS&AD Insurance Group Holdings
4,115.00
1,285.08
45.41%
JP:8630
Sompo Holdings
5,994.00
1,710.35
39.93%
JP:8473
SBI Holdings
3,103.00
1,395.47
81.72%
JP:8795
T&D Holdings
4,053.00
1,325.20
48.58%
JP:7181
JAPAN POST INSURANCE Co., Ltd.
1,598.00
700.01
77.95%
Dai-ichi Life Holdings Corporate Events
Dai-ichi Life Holdings Completes ¥100 Billion Share Buyback Program
Mar 10, 2026
Dai-ichi Life Holdings has completed a share repurchase program authorized by its board in May 2025, buying back a total of 79,682,200 common shares for approximately 99.99 billion yen through open-market transactions using a discretionary trading...
Dai-ichi Life Completes Restricted Stock Compensation Share Issuance
Mar 4, 2026
Dai-ichi Life Holdings has completed payment for the issuance of 6,000 new shares of common stock as restricted stock compensation under its stock remuneration scheme, following a board approval on February 13, 2026. The shares, issued at ¥1,...
Dai-ichi Life Nears Completion of ¥100 Billion Share Buyback Program
Mar 2, 2026
Dai-ichi Life Holdings has reported progress on its ongoing share repurchase program, buying 10,641,000 common shares on the open market between February 1 and February 28, 2026, for a total of about ¥16.2 billion. The repurchases were execut...
Dai-ichi Life to Acquire 15% Stake in Infomart Through Strategic Alliance
Feb 13, 2026
Dai-ichi Life Holdings has entered into a capital and business alliance with Infomart Corporation and will acquire a significant minority stake through a combination of newly issued shares and disposal of treasury shares via third-party allotment....
Dai-ichi Life Issues New Restricted Shares to Align Executive Pay With Shareholders
Feb 13, 2026
Dai-ichi Life Holdings has approved the issuance of 6,000 new common shares as restricted stock compensation to executive officers and directors of the company and its group company Benefit One Inc. The program is part of an established stock remu...
Dai-ichi Life Injects ¥7 Billion Into Employee Stock Ownership Plan
Feb 13, 2026
Dai-ichi Life Holdings will make an additional ¥7 billion contribution to its Japan Employee Stock Ownership Plan trust to fund the purchase of company shares for future employee stock grants. The trustee plans to acquire up to 7 million shar...
Dai-ichi Life Revamps Leadership and Structure to Sharpen Insurance and Asset Management Focus
Feb 13, 2026
Dai-ichi Life Holdings has announced a major overhaul of its management structure, effective April 1, 2026, aimed at accelerating growth across its core businesses. The group will replace its current Protection (Japan) and Retirement, Saving and A...
Dai-ichi Life Lifts Earnings Outlook and Dividend on Strong Investment Gains
Feb 13, 2026
Dai-ichi Life Holdings has raised its consolidated earnings forecast for the fiscal year ending March 31, 2026, citing higher investment income at The Dai-ichi Frontier Life Insurance Co. and increased gains on sales of securities at The Dai-ichi ...
Neo First Life Discloses Nine-Month Financial Results for Fiscal 2025
Feb 13, 2026
The Neo First Life Insurance Company, a subsidiary of Dai-ichi Life Holdings, has disclosed its unaudited financial results for the nine months ended December 31, 2025, along with detailed supplementary materials. The release outlines business hig...
Dai-ichi Frontier Life Publishes Nine-Month Financial Results for FY2025
Feb 13, 2026
The Dai-ichi Frontier Life Insurance Co., Ltd., a core subsidiary of Dai-ichi Life Holdings, has released its financial results for the nine months ended December 31, 2025. The disclosure includes key materials such as business highlights, investm...
Dai-ichi Life Publishes Nine-Month Financial Results to December 2025
Feb 13, 2026
Dai-ichi Life Insurance, the main operating company of Dai-ichi Life Holdings, has released supplementary materials detailing its financial performance for the nine months ended December 31, 2025. The disclosure outlines business highlights, gener...
Dai-ichi Life Leans on Overseas Growth as Profits Rise and Capital Remains Strong
Feb 13, 2026
Dai-ichi Life Holdings reported broadly stable top-line performance for the nine months ended December 31, 2025, with consolidated premium and other income edging down 0.3% to ¥5.09 trillion even as annualized net premiums of policies in forc...
Dai-ichi Life Holdings Issues Q3 FY2025 Financial Outline for Nine-Month Period
Feb 13, 2026
Dai-ichi Life Holdings released outline materials summarizing its financial results for the nine months ended December 31, 2025, as part of its Q3 fiscal 2025 disclosure. The announcement signals the company’s ongoing commitment to regular, ...
Dai-ichi Life Posts Higher Nine-Month Profit and Lifts Full-Year Forecasts
Feb 13, 2026
Dai-ichi Life Holdings reported consolidated ordinary revenues of ¥8.32 trillion for the nine months ended December 31, 2025, up 6.1% year-on-year, with ordinary profit rising 7.2% to ¥597.7 billion and net income attributable to shareho...
Dai-ichi Life Details Progress of Large-Scale Share Buyback Program
Feb 2, 2026
Dai-ichi Life Holdings has reported the latest status of its ongoing share repurchase program, buying back 4,733,800 common shares for a total of about 6.45 billion yen on the open market between January 1 and January 31, 2026, via discretionary t...
Dai-ichi Life Expands Shareholder Benefits to Investors Holding 100 Shares or More
Jan 14, 2026
Dai-ichi Life Holdings has decided to expand its shareholder benefit program to align with its April 2025 stock split and to make its services more accessible to a wider base of retail investors. From the fiscal year ending March 31, 2026, shareho...
Dai-ichi Life Reports Progress on Large-Scale Share Buyback Program
Jan 5, 2026
Dai-ichi Life Holdings has disclosed the latest status of its ongoing share repurchase program, reporting that it bought back 6,802,500 common shares on the open market between December 1 and December 31, 2025, at a total cost of approximately ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.